Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.
This comparison of intermittent versus extended-infusion piperacillin-tazobactam among patients with Gram-negative infections revealed similar mortality and length of stay. Outcomes remained similar when stratified by MIC value.